Lexpos News

Community Pharmacy England has set out seven steps to help reconcile claims for Serious Shortage Protocols (SSPs). Our new guidance aims to support pharmacy teams in spot checking that the number of fees paid for supplying items in accordance with an SSP matches the number declared as part of their end of month submission. We [...]

The post Our new factsheet helps monitor your pharmacy’s SSP totals appeared first on Community Pharmacy England.

The contact details to make a claim under the fraudulent prescription reward scheme have been updated in Part XIVA of the September 2023 Drug Tariff. This follows concerns raised by pharmacy owners and escalated to the Department of Health and Social Care (DHSC) by Community Pharmacy England. Pharmacists who are eligible to claim a reward [...]

The post New Contact Details for Fraudulent Prescription Form Reward Scheme appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Loceryl 5% w/v Medicated Nail Lacquer (5.0 ml) Galderma (U.K.) Limited Drug alert number: EL (23)A/31 Date issued: 29 August 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Loceryl 5% w/v Medicated Nail Lacquer (5.0 ml) Galderma (U.K.) Limited. [...]

The post MHRA Class 4 Medicines Defect Information: Loceryl 5% w/v Medicated Nail Lacquer (5.0 ml) appeared first on Community Pharmacy England.

This summer the Government announced the Windsor Framework, which sets out the long-term arrangements for the supply of medicines into Northern Ireland. It will ensure that medicines can be approved and licensed on a UK-wide basis by the Medicines and Healthcare products Regulatory Agency (MHRA) and provides for the disapplication of European Union (EU) Falsified [...]

The post Windsor Agreement on the supply of medicines into Northern Ireland appeared first on Community Pharmacy England.